Beta-lactamase inhibitors and uses thereof
US10500211B2 · kind B2 · utility
0Cited by
11References
26Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 29, 2018 |
| Grant date | Dec 10, 2019 |
| Priority date | — |
| Expiry date | Aug 29, 2038 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D471/08
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
β-Lactamase inhibiting compounds, therapeutic methods of using the β-lactamase inhibiting compounds, particularly in combination with β-lactam antibiotics and pharmaceutical compositions thereof are disclosed. The β-lactamase inhibiting compounds are suitable for oral administration.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.